
Building the governance, MSL capability, KOL strategy, and scientific infrastructure that positions Medical Affairs as the engine of launch success.

End-to-end capability building across commercial teams, payer strategy, reimbursement pathways, and sales force readiness, aligned to your launch window.

Compliance, clinical, and commercial capability infrastructure for medtech teams navigating complex regulatory environments and competitive launches.

Specialized capability programs that build scientific credibility, payer fluency, and field readiness for teams working across complex biologic and biosimilar landscapes.

SOPs, compliance frameworks, and performance infrastructure that give pharma operations teams the governance backbone every launch requires.

From Series B to international launch — ACMA partners with biotech companies to build the capability infrastructure that scales with their pipeline and team.

AI-enabled capability programs and technical solutions that help health tech companies build credibility, compliance, and commercial readiness across the value chain.